Deng Nanjie, Hoyte Ashley, Mansour Yara E, Mohamed Mosaad S, Fuchs James R, Engelman Alan N, Kvaratskhelia Mamuka, Levy Ronald
Center for Biophysics & Computational Biology/ICMS, Department of Chemistry, Temple University, Philadelphia, Pennsylvania, 19122.
Center for Retrovirus Research and College of Pharmacy, The Ohio State University, Columbus, Ohio, 43210.
Protein Sci. 2016 Nov;25(11):1911-1917. doi: 10.1002/pro.2997. Epub 2016 Aug 17.
Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) bind at the dimer interface of the IN catalytic core domain (CCD), and potently inhibit HIV-1 by promoting aberrant, higher-order IN multimerization. Little is known about the structural organization of the inhibitor-induced IN multimers and important questions regarding how ALLINIs promote aberrant IN multimerization remain to be answered. On the basis of physical chemistry principles and from our analysis of experimental information, we propose that inhibitor-induced multimerization is mediated by ALLINIs directly promoting inter-subunit interactions between the CCD dimer and a C-terminal domain (CTD) of another IN dimer. Guided by this hypothesis, we have built atomic models of inter-subunit interfaces in IN multimers by incorporating information from hydrogen-deuterium exchange (HDX) measurements to drive protein-protein docking. We have also developed a novel free energy simulation method to estimate the effects of ALLINI binding on the association of the CCD and CTD. Using this structural and thermodynamic modeling approach, we show that multimer inter-subunit interface models can account for several experimental observations about ALLINI-induced multimerization, including large differences in the potencies of various ALLINIs, the mechanisms of resistance mutations, and the crucial role of solvent exposed R-groups in the high potency of certain ALLINIs. Our study predicts that CTD residues Tyr226, Trp235 and Lys266 are involved in the aberrant multimer interfaces. The key finding of the study is that it suggests the possibility of ALLINIs facilitating inter-subunit interactions between an external CTD and the CCD-CCD dimer interface.
变构HIV-1整合酶(IN)抑制剂(ALLINI)结合于IN催化核心结构域(CCD)的二聚体界面,并通过促进异常的高阶IN多聚化来有效抑制HIV-1。关于抑制剂诱导的IN多聚体的结构组织知之甚少,关于ALLINI如何促进异常IN多聚化的重要问题仍有待解答。基于物理化学原理并通过对实验信息的分析,我们提出抑制剂诱导的多聚化是由ALLINI直接促进CCD二聚体与另一个IN二聚体的C末端结构域(CTD)之间的亚基间相互作用介导的。在这一假设的指导下,我们通过整合氢氘交换(HDX)测量信息以驱动蛋白质-蛋白质对接,构建了IN多聚体中亚基间界面的原子模型。我们还开发了一种新颖的自由能模拟方法来估计ALLINI结合对CCD和CTD缔合的影响。使用这种结构和热力学建模方法,我们表明多聚体亚基间界面模型可以解释关于ALLINI诱导的多聚化的几个实验观察结果,包括各种ALLINI效力的巨大差异、耐药突变的机制以及溶剂暴露的R基团在某些ALLINI高效力中的关键作用。我们的研究预测CTD残基Tyr226、Trp235和Lys266参与异常多聚体界面。该研究的关键发现是它表明了ALLINI促进外部CTD与CCD-CCD二聚体界面之间亚基间相互作用的可能性。